blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4022312

EP4022312 - METHOD OF ISOLATING CIRCULATING NUCLEOSOMES [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  03.06.2022
Database last updated on 15.06.2024
FormerThe international publication has been made
Status updated on  05.03.2021
Formerunknown
Status updated on  01.09.2020
Most recent event   Tooltip18.08.2023New entry: Renewal fee paid 
Applicant(s)For all designated states
Belgian Volition Srl
Rue Phocas Lejeune 22
5032 Isnes / BE
[2022/27]
Inventor(s)01 / ECCLESTON, Mark Edward
c/o Belgian Volition SPRL
22 Rue Phocas Lejeune
5032 Isnes / BE
02 / MICALLEF, Jacob Vincent
c/o Belgian Volition SPRL
22 Rue Phocas Lejeune
5032 Isnes / BE
 [2022/27]
Representative(s)Sagittarius IP
Marlow International
Parkway
Marlow SL7 1YL / GB
[N/P]
Former [2022/27]Pond, Elizabeth Grace Catherine
Sagittarius IP
Marlow International
Parkway
Marlow SL7 1YL / GB
Application number, filing date20760875.327.08.2020
[2022/27]
WO2020EP74026
Priority number, dateGB2019001225127.08.2019         Original published format: GB 201912251
GB2019001673518.11.2019         Original published format: GB 201916735
GB2020000654704.05.2020         Original published format: GB 202006547
[2022/27]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021038010
Date:04.03.2021
Language:EN
[2021/09]
Type: A1 Application with search report 
No.:EP4022312
Date:06.07.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 04.03.2021 takes the place of the publication of the European patent application.
[2022/27]
Search report(s)International search report - published on:EP04.03.2021
ClassificationIPC:G01N33/574, G01N33/68, C12Q1/6886
[2022/27]
CPC:
G01N33/6875 (EP,CN,IL,KR); C12Q1/6806 (EP,CN,IL,KR,US); C12Q1/6886 (CN,US);
C12Q1/6804 (EP,CN,IL,KR); G01N33/57488 (EP,CN,IL,KR,US); C12Q1/6851 (US);
C12Q2563/131 (IL,KR); C12Q2565/531 (IL); C12Q2600/154 (US);
C12Q2600/156 (US) (-)
C-Set:
C12Q1/6804, C12Q2563/131, C12Q2565/531 (EP);
C12Q1/6804, C12Q2565/531, C12Q2563/131 (CN);
C12Q1/6806, C12Q2563/131, C12Q2565/531 (EP);
C12Q1/6806, C12Q2565/531, C12Q2563/131 (CN)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/27]
TitleGerman:VERFAHREN ZUR ISOLIERUNG ZIRKULIERENDER NUKLEOSOMEN[2022/27]
English:METHOD OF ISOLATING CIRCULATING NUCLEOSOMES[2022/27]
French:PROCÉDÉ D'ISOLEMENT DE NUCLÉOSOMES CIRCULANTS[2022/27]
Entry into regional phase14.03.2022National basic fee paid 
14.03.2022Designation fee(s) paid 
14.03.2022Examination fee paid 
Examination procedure14.03.2022Examination requested  [2022/27]
14.03.2022Date on which the examining division has become responsible
07.10.2022Amendment by applicant (claims and/or description)
Fees paidRenewal fee
19.08.2022Renewal fee patent year 03
18.08.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[ID]WO2017068371  (BELGIAN VOLITION SPRL [BE]) [ID] 1-3,9-14,19-22 * page 8, paragraph last - page 9, paragraph first; claims 1-21 *;
 [A]  - SAKAMOTO J ET AL, "Immunoprecipitation of nucleosomal DNA is a novel procedure to improve the sensitivity of serum screening for the p16 hypermethylation associated with colon cancer", CANCER EPIDEMIOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 34, no. 2, ISSN 1877-7821, (20100401), pages 194 - 199, (20100202), XP026993084 [A] 1-5,9-14,19-22 * page 195, column l, paragraph last - column r, paragraph first *
 [A]  - A. T. J. I. GO ET AL, "Non-invasive aneuploidy detection using free fetal DNA and RNA in maternal plasma: recent progress and future possibilities", HUMAN REPRODUCTION UPDATE, (20101112), vol. 17, no. 3, doi:10.1093/humupd/dmq054, ISSN 1355-4786, pages 372 - 382, XP055052831 [A] 1-5,9-14,19-22 * page 379, column r, paragraph 2 *

DOI:   http://dx.doi.org/10.1093/humupd/dmq054
 [A]  - MATTHEW?W. SNYDER ET AL, "Cell-free DNA Comprises an In?Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin", CELL, AMSTERDAM, NL, (20160114), vol. 164, no. 1-2, doi:10.1016/j.cell.2015.11.050, ISSN 0092-8674, pages 57 - 68, XP055367434 [A] 1-5,9-14,19-22 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.cell.2015.11.050
 [A]  - LOUISE RASMUSSEN ET AL, "Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer", ONCOTARGET, United States, (20180213), vol. 9, no. 12, doi:10.18632/oncotarget.21908, ISSN 1949-2553, XP055656897 [A] 1-5,9-14,19-22 * the whole document *

DOI:   http://dx.doi.org/10.18632/oncotarget.21908
 [A]  - GERBEN MARSMAN ET AL, "Extracellular histones, cell-free DNA, or nucleosomes: differences in immunostimulation", CELL DEATH AND DISEASE, (20161208), vol. 7, no. 12, doi:10.1038/cddis.2016.410, page e2518, XP055333785 [A] 1-5,9-14,19-22 * page 6, column r, paragraph 4 *

DOI:   http://dx.doi.org/10.1038/cddis.2016.410
by applicantWO2005019826
 WO2013030577
 WO2013030579
 WO2013030578
 WO2013084002
 WO2017068371
    - BAO et al., EMBO J., (20040000), vol. 23, pages 3314 - 3324
    - BONISCH et al., Nucleic Acids Res., (20120000), vol. 40, no. 13, pages 5951 - 5964
    - BOWERMANWERESZCZYNSKI, Biophys. J., (20160000), vol. 110, pages 327 - 337
    - CHURCH et al., Gut, (20140000), vol. 63, pages 317 - 325
    - CONDE E SILVA et al., J. Mol. Biol., (20070000), vol. 370, pages 555 - 573
    - CROWLEY et al., Nat. Rev. Clin. Oncol., (20130000), vol. 10, no. 8, pages 472 - 484
    - DAI et al., J. Vis. Exp., (20110000), vol. 50, page 2593
    - DHAENENS et al., Bioessays, (20140000), vol. 37, pages 70 - 79
    - DHASARATHYWADE, Mutat Res., (20080000), vol. 647, pages 39 - 43
    - FONG et al., Clin. Chem., (20090000), vol. 55, no. 3, pages 587 - 589
    - GUERRERO-PRESTON et al., Epigenetics, (20070000), vol. 2, no. 4, pages 223 - 226
    - HOLDENRIEDER et al., Int. J. Cancer (Pred. Oncol., (20010000), vol. 95, pages 114 - 120
    - HOLDENRIEDERSTIEBER, Crit. Rev. Clin. Lab. Sci., (20090000), vol. 46, no. 1, pages 1 - 24
    - JUNG et al., Clin. Chimica Acta., (20100000), vol. 411, pages 1611 - 1624
    - MOULIERE et al., Sci Transl Med., (20180000), vol. 10, page 466
    - NALABOTHULA et al., BMC Genomics, (20140000), vol. 15, page 92
    - NEWMAN et al., Nat. Med., (20140000), vol. 20, no. 5, pages 548 - 554
    - SALGAME et al., Nucleic Acids Res., (19970000), vol. 25, no. 3, pages 680 - 681
    - SCHRADER et al., PLoS ONE, (20150000), vol. 10, no. 10, page e0140076
    - SCHWARZENBACH et al., Nat. Rev. Cancer, (20110000), vol. 11, no. 6, pages 426 - 437
    - SINA et al., Nat. Comm., (20180000), vol. 9, page 4915
    - SNYDER et al., Cell, (20160000), vol. 164, pages 57 - 68
    - SOARES et al., Cancer, (19990000), vol. 85, no. 1, pages 112 - 118
    - SULTANOV et al., AIMS Genetics, (20170000), vol. 4, no. 1, pages 21 - 31
    - VAN NIEUWENHUIJZE et al., Ann. Rheum. Dis., (20030000), vol. 62, pages 10 - 14
    - WIESLERWEINZIERL, Methods Mol. Biol., Humana Press, (20150000), vol. 1286, pages 97 - 106
    - YANG et al., Int. J. Oncol., (20180000), vol. 52, no. 4, pages 1235 - 1245
    - YIKIM, BMB Reports, (20180000), vol. 51, no. 5, pages 211 - 218
    - ZHOU et al., Semin. Oncol., (20120000), vol. 39, no. 4, pages 440 - 448
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.